Recombinant Type IV secretion system protein ptlA homolog (ptlA)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Type IV Secretion System Protein PtlA Homolog (PtlA)

The recombinant Type IV secretion system protein PtlA homolog (PtlA) is a purified, histidine-tagged (His-tagged) protein derived from Bordetella bronchiseptica. It is a component of the bacterial Type IV secretion system (T4SS), a macromolecular machinery responsible for transferring DNA or effector proteins across bacterial membranes. This protein is critical for studying T4SS assembly, function, and pathogenicity mechanisms in Gram-negative bacteria.

Basic Properties

AttributeValue
Gene NameptlA
UniProt IDQ7WDU3
SpeciesBordetella bronchiseptica
SourceEscherichia coli (recombinant expression)
TagN-terminal His tag
Protein LengthFull-length mature protein (32–102 amino acids)
AA SequenceQASGGLQRVNSFMAGIVTVLRGASVATVTIAIIWAGYKLLFRHADVLDVVRVVLAGLLIGASAEIARYLLT

Note: The sequence corresponds to the mature protein (32–102 aa) fused to a His tag for purification .

Recombinant Expression and Purification

PtlA is expressed in E. coli and purified via affinity chromatography using the His tag. Key specifications include:

ParameterDetail
Purity>90% (SDS-PAGE confirmed)
FormLyophilized powder
Storage BufferTris/PBS-based buffer, 6% trehalose, pH 8.0
ReconstitutionDeionized sterile water (0.1–1.0 mg/mL) with optional glycerol (5–50%)
Storage-20°C/-80°C (long-term); -4°C (working aliquots)

Handling Notes:

  • Avoid repeated freeze-thaw cycles.

  • Aliquot for multiple uses .

Comparative Analysis of Recombinant PtlA Products

ProductHostFormPuritySource
RFL7259BF (Full-length)E. coliLyophilized powder>90%Creative Biomart
Partial sequence (e.g., 32–102 aa)E. coli/YeastLyophilized powder≥85%MyBioSource
Multispecies (e.g., B. parapertussis)E. coliLyophilized powder≥85%MyBioSource

Key Differences:

  • Full-length vs. Partial: Full-length versions include the entire mature protein sequence, while partial fragments target specific regions for structural studies.

  • Host Systems: E. coli is the primary host, but yeast and baculovirus systems are alternatives for post-translational modifications .

Product Specs

Form
Lyophilized powder
Note: We will prioritize shipping the format currently in stock. However, if you have specific format requirements, please indicate them in your order. We will accommodate your request as best as possible.
Lead Time
Delivery time may vary depending on the purchasing method and location. For specific delivery times, please consult your local distributors.
Note: Our proteins are shipped with standard blue ice packs. If you require dry ice shipping, please inform us in advance, as additional fees will apply.
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Reconstitution
We recommend centrifuging the vial briefly before opening to ensure the contents settle at the bottom. Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default glycerol concentration is 50%. Customers can use this as a reference.
Shelf Life
Shelf life is influenced by factors such as storage conditions, buffer components, temperature, and the protein's inherent stability.
Generally, liquid forms have a shelf life of 6 months at -20°C/-80°C. Lyophilized forms have a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is necessary for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type will be determined during the manufacturing process.
The tag type will be determined during production. If you have specific tag requirements, please inform us. We will prioritize development according to your specifications.
Synonyms
ptlA; BPP4309; Type IV secretion system protein PtlA homolog
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
34-102
Protein Length
Full Length of Mature Protein
Species
Bordetella parapertussis (strain 12822 / ATCC BAA-587 / NCTC 13253)
Target Names
ptlA
Target Protein Sequence
GGGLQRVNHFMASIVVVLRGASVATVTIAIIWAGYKLLFRHADVLDVVRVVLAGLLIGAS AEIARYLLT
Uniprot No.

Target Background

Database Links

KEGG: bpa:BPP4309

Protein Families
PtlA family
Subcellular Location
Cell membrane; Multi-pass membrane protein.

Q&A

What is the PtlA protein and what is its role in Type IV secretion systems?

PtlA is one of the nine Ptl proteins (PtlA-I) that constitute the pertussis toxin secretion system in Bordetella pertussis. The Ptl proteins form a specialized T4SS that mediates the export of pertussis toxin across the bacterial outer membrane. PtlA is essential for the assembly and function of this secretion machinery, as mutations in ptlA genes result in deficiency of pertussis toxin secretion . Unlike some other T4SS components that may have enzymatic activities (such as PtlE with its peptidoglycanase activity), PtlA primarily serves a structural role within the secretion complex, contributing to the architecture of the secretion channel spanning the bacterial envelope.

How do PtlA homologs differ across bacterial species with T4SS?

PtlA homologs exist across various bacterial species possessing T4SS machinery, though with considerable variation in structure and function. The T4SS family includes two major subfamilies: conjugation systems mediating interbacterial DNA transfer and effector translocators delivering macromolecules into target cells . PtlA homologs may adapt structurally to accommodate these diverse functions. For instance, in Agrobacterium tumefaciens, the VirB/VirD4 T4SS contains components homologous to PtlA that facilitate transfer of T-DNA into plant cells . Similarly, the Legionella pneumophila Dot/Icm system and Helicobacter pylori Cag T4SS contain PtlA-like proteins adapted to their specific secretion requirements . These homologs maintain core structural features while exhibiting variation in specific domains that facilitate their specialized functions within different bacterial contexts.

What conserved domains and motifs characterize PtlA and its homologs?

While the search results don't specifically detail PtlA domains, we can infer from related T4SS proteins that PtlA likely contains:

  • Transmembrane domains - facilitating anchoring within the bacterial membrane

  • Periplasmic domains - mediating interactions with other T4SS components

  • Protein-protein interaction motifs - enabling complex assembly with other Ptl proteins

Based on studies of other Ptl proteins such as PtlE, which contains a conserved glycosyl hydrolase domain with catalytically important acidic residues (D53 and E62) , PtlA may possess conserved motifs that mediate specific interactions within the secretion complex. These structural features would be expected to be evolutionarily conserved among PtlA homologs to maintain the core functionality of the T4SS machinery.

What are the optimal expression systems for recombinant PtlA production?

For recombinant PtlA production, researchers should consider the following expression systems based on experimental objectives:

Bacterial Expression Systems:

  • E. coli BL21(DE3) with pET vector systems - allows for high-yield expression with IPTG induction

  • E. coli C41/C43 strains - specialized for membrane protein expression, beneficial for PtlA's transmembrane domains

Expression Optimization Strategies:

  • Reduce expression temperature to 16-18°C to enhance proper folding

  • Use fusion tags (His, GST, MBP) to improve solubility and facilitate purification

  • Consider codon optimization for the expression host

  • Employ periplasmic targeting sequences for proper localization

When expressing T4SS components like PtlA, it's crucial to optimize conditions that prevent protein aggregation while maintaining native conformation. As demonstrated with other T4SS proteins, expression of truncated functional domains may improve yield and solubility compared to full-length protein . The research approach used for PtlE, involving specific domain expression and site-directed mutagenesis, provides a valuable template for PtlA studies .

How can researchers effectively study PtlA-protein interactions within the T4SS complex?

Investigating PtlA interactions within the T4SS complex requires multi-faceted approaches:

In Vitro Methods:

  • Co-immunoprecipitation (Co-IP) with tagged PtlA to identify binding partners

  • Bacterial two-hybrid assays to screen for direct interactions

  • Surface plasmon resonance (SPR) to determine binding kinetics

  • Cross-linking coupled with mass spectrometry to capture transient interactions

Structural Biology Approaches:

  • X-ray crystallography of PtlA domains with interaction partners

  • Cryo-electron microscopy (cryo-EM) to visualize the intact T4SS complex

  • NMR studies of smaller interaction domains

Recent advances in T4SS structural biology have employed cryo-EM and cryo-electron tomography to elucidate the architecture of complete T4SS complexes . These techniques have proven particularly valuable for understanding the spatial organization of components like PtlA within the larger secretion machinery. Similar to studies of the Legionella pneumophila Dot/Icm system, where adaptor proteins like IcmS and IcmW were found to mediate effector recruitment , researchers should investigate whether PtlA interacts with similar adaptor proteins to facilitate substrate recognition and transport.

What genetic manipulation strategies are most effective for studying ptlA gene function?

Genetic Manipulation Approaches:

  • Targeted Gene Disruption:

    • Allelic exchange mutagenesis to generate clean ptlA deletions

    • Insertion of antibiotic resistance cassettes to disrupt ptlA

    • CRISPR-Cas9 genome editing for precise genetic modifications

  • Complementation Analysis:

    • Introduction of wild-type ptlA on expression plasmids

    • Trans-complementation with homologs from other species

    • Domain-swap experiments to identify functional regions

  • Site-Directed Mutagenesis:

    • Generation of point mutations in conserved residues

    • Construction of chimeric proteins to analyze domain functions

Building on strategies used for PtlE studies , researchers should create amino acid substitutions in conserved regions of PtlA to identify functionally critical residues. For instance, PtlE's activity was characterized by generating D53A and E62A mutations in catalytic residues . Similarly, researchers studying PtlA should identify conserved regions through sequence alignment and target these for mutagenesis. Plasmid-based expression systems with inducible promoters can facilitate functional complementation studies to verify the effects of these mutations.

How does the antagonistic activity of T4SS affect PtlA function and bacterial population dynamics?

Recent research has revealed an unexpected antagonistic property of certain T4SS complexes that can eliminate target bacterial cells through a contact-dependent mechanism . This antagonistic activity appears to be:

  • Independent of molecular cargo delivery

  • Dependent on direct cell-to-cell contact

  • Effective against a range of Gram-negative bacteria

  • Observed in T4SS from different conjugative plasmids (RP4, R388)

For PtlA researchers, this raises important questions about whether PtlA homologs contribute to this antagonistic function. The antagonistic property could represent an evolutionary adaptation of T4SS that extends beyond their canonical secretion roles, potentially functioning as a competitive mechanism in mixed bacterial populations .

Researchers should investigate:

  • Whether PtlA structural features correlate with antagonistic potential

  • If PtlA interacts with resistance genes that protect against T4SS-mediated antagonism

  • How PtlA contributes to the cell-to-cell contact necessary for antagonistic activity

  • Whether targeting PtlA could modulate T4SS antagonistic function in mixed bacterial communities

What is the structural basis for substrate recognition and specificity in PtlA-containing T4SS?

Understanding substrate recognition represents one of the most complex challenges in T4SS research. For PtlA-containing systems, researchers should consider:

Substrate Recognition Mechanisms:

  • C-terminal Signal Sequences:
    Studies of the Legionella pneumophila Dot/Icm system identified effectors with C-terminal translocation signals composed of short polar and negatively charged amino acids . The "E block motif" (clusters of glutamate residues) within 17-10 residues from the C-terminus appears particularly important .

  • Adaptor Protein-Mediated Recognition:
    Multiple T4SS utilize adaptor proteins that modulate substrate engagement:

    • In Legionella, the DotL protein's C-terminal domain binds adaptors IcmS and IcmW

    • Some effectors carry an FxxxLxxxK motif that mediates specific contacts with the adaptor LvgA

  • Structural Interface Analysis:
    The crystal structure of T4SS components like DotL in complex with adaptors has revealed a bell-shaped "substrate receptor module" that recruits effectors through specific molecular contacts.

For PtlA research, investigators should determine:

  • Whether PtlA directly participates in substrate binding

  • If PtlA interacts with adaptor proteins analogous to IcmS/IcmW

  • How conformational changes in PtlA might influence substrate channel dynamics

  • If PtlA contains binding domains for specific cargo recognition motifs

How do post-translational modifications regulate PtlA activity within T4SS complexes?

Post-translational modifications (PTMs) can dramatically influence protein function, yet their role in regulating T4SS components remains understudied. For PtlA research, key considerations include:

Potential Regulatory PTMs:

  • Phosphorylation - potentially regulating assembly/disassembly of T4SS complexes

  • Acetylation - possibly affecting protein-protein interactions

  • Proteolytic processing - potentially activating or inactivating specific domains

  • Disulfide bond formation - potentially stabilizing tertiary structure

Researchers should employ phosphoproteomic approaches to identify modification sites on PtlA under different physiological conditions. Mass spectrometry coupled with enrichment strategies for specific PTMs can elucidate the modification landscape of PtlA. Additionally, site-directed mutagenesis of potential modification sites (e.g., converting phosphorylatable serine/threonine residues to alanine) can help determine the functional significance of these modifications.

How can researchers optimize experimental design when studying PtlA within complex T4SS structures?

Studying individual components like PtlA within the context of large macromolecular T4SS complexes presents significant experimental design challenges. Researchers should consider:

Experimental Design Principles:

  • Hybrid Methodological Approaches:
    Combine structural techniques (cryo-EM, X-ray crystallography) with functional assays to correlate structure with activity.

  • Retrospective Design Sampling:
    Apply decision theoretic optimal experimental design methods to improve analysis of large datasets through retrospective designed sampling . This approach can help manage the heterogeneity and size of data typically generated in structural studies of complex systems like T4SS.

  • Dimension Reduction Strategies:
    Use computational approaches to identify the most informative dimensions in complex datasets:

    • Principal Component Analysis (PCA)

    • t-SNE (t-Distributed Stochastic Neighbor Embedding)

    • UMAP (Uniform Manifold Approximation and Projection)

  • Iterative Design Optimization:
    Employ active learning approaches where each experimental iteration informs the design of subsequent experiments, gradually refining the structural and functional model of PtlA within the T4SS complex .

This methodological framework allows researchers to efficiently explore the structural-functional relationship of PtlA despite the complexity of the T4SS system, enabling more targeted hypotheses and experimental designs.

What bioinformatic approaches best predict functional domains and evolutionary relationships among PtlA homologs?

Comprehensive Bioinformatic Analysis Workflow:

  • Sequence-Based Analysis:

    • Multiple sequence alignment (MSA) of PtlA homologs using MUSCLE or MAFFT

    • Identification of conserved motifs using MEME or GLAM2

    • Prediction of transmembrane regions using TMHMM and TMpred

    • Secondary structure prediction via PSIPRED or JPred

  • Structural Prediction:

    • Template-based modeling using homology to known T4SS structures

    • Ab initio prediction for unique domains using AlphaFold2 or RoseTTAFold

    • Molecular dynamics simulations to predict conformational flexibility

  • Evolutionary Analysis:

    • Phylogenetic tree construction using Maximum Likelihood or Bayesian methods

    • Selection pressure analysis (dN/dS ratio) to identify functionally important residues

    • Ancestral sequence reconstruction to trace evolutionary trajectories

  • Functional Annotation Transfer:

    • Integration of predictions with experimental data from homologous systems

    • Cross-validation using multiple prediction algorithms

    • Confidence scoring for predicted functional annotations

This integrated approach provides a robust framework for predicting PtlA structural features and evolutionary relationships, generating testable hypotheses for experimental validation.

How should researchers interpret contradictory findings in PtlA structure-function studies?

Contradictory findings are common in complex biological systems like T4SS. When faced with discrepancies in PtlA research, consider:

Systematic Resolution Framework:

  • Methodological Variations Analysis:

    • Create a comparative table of experimental conditions across studies

    • Identify key methodological differences that might explain contradictions

    • Evaluate sensitivity of results to specific experimental parameters

  • Biological Context Consideration:

    • Assess whether contradictions relate to species-specific adaptations

    • Consider whether growth conditions or physiological states impact findings

    • Evaluate if genetic background differences explain contradictory results

  • Resolution Experiments Design:

    • Design experiments specifically targeting the contradictory findings

    • Use orthogonal methodologies to independently verify results

    • Develop standardized protocols to enhance reproducibility

  • Integrated Model Development:

    • Construct models accommodating seemingly contradictory findings

    • Consider if contradictions represent different states of a dynamic system

    • Develop mathematical models to test whether contradictions can be reconciled

By systematically addressing contradictions, researchers can develop more comprehensive and accurate models of PtlA function within T4SS complexes.

What emerging technologies will advance our understanding of PtlA function in T4SS?

Several cutting-edge technologies are poised to revolutionize PtlA research:

  • Cryo-Electron Tomography Advancements:
    Recent advances in cryo-ET have enabled visualization of intact T4SS complexes in their native membrane environment . Further refinements in this technology will allow for higher resolution analysis of PtlA's position and interactions within the secretion machinery.

  • Single-Molecule Techniques:

    • smFRET (single-molecule Förster Resonance Energy Transfer) to track conformational changes

    • Single-molecule tracking to visualize PtlA dynamics during secretion

    • Optical tweezers to measure forces associated with substrate translocation

  • Advanced Genetic Engineering:

    • CRISPR interference (CRISPRi) for precise temporal control of ptlA expression

    • Optogenetic control of PtlA activity to study real-time dynamics

    • Expanded genetic code incorporation for site-specific labeling

  • Integrative Structural Biology:
    Combining multiple structural techniques (X-ray crystallography, NMR, cryo-EM, cross-linking mass spectrometry) to develop comprehensive models of PtlA within the T4SS complex at near-atomic resolution.

These emerging technologies will enable researchers to address fundamental questions about PtlA dynamics, conformational changes, and molecular interactions during the secretion process.

How might therapeutic targeting of PtlA impact bacterial pathogenesis?

Understanding PtlA structure and function opens possibilities for therapeutic intervention:

Therapeutic Targeting Strategies:

  • Inhibitor Design Approaches:

    • Structure-based design of small molecules targeting critical PtlA domains

    • Peptide mimetics disrupting PtlA interactions with other T4SS components

    • Allosteric modulators affecting PtlA conformational dynamics

  • Pathogenesis Intervention Points:

    • Blocking toxin secretion in pathogens like Bordetella pertussis

    • Disrupting effector translocation in intracellular pathogens

    • Inhibiting T4SS-mediated horizontal gene transfer of virulence or resistance genes

  • Therapeutic Outcome Assessment:

    • Evaluation of virulence attenuation in animal models

    • Analysis of resistance development mechanisms

    • Combination therapy approaches to enhance efficacy

The antagonistic property of some T4SS complexes suggests that engineered T4SS systems with modified PtlA components might also serve as novel antimicrobial strategies, selectively targeting pathogenic bacteria in mixed populations.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.